40 Participants Needed

Radiosurgery for Essential Tremor

KW
LC
FS
MB
AB
Overseen ByAsim Bag, MD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Alabama at Birmingham
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

What data supports the effectiveness of the treatment Unframed Virtual Cone for essential tremor?

Research shows that frameless radiosurgery, which is similar to the Unframed Virtual Cone treatment, can effectively reduce tremors in patients with essential tremor and Parkinson's disease. Studies indicate that targeting the ventral intermediate nucleus of the thalamus with this noninvasive approach can lead to significant tremor improvement without added side effects.12345

Is radiosurgery for essential tremor safe?

Radiosurgery for essential tremor, including techniques like gamma knife thalamotomy, is generally considered safe and well-tolerated. Most complications are mild and temporary, such as numbness or weakness, though rare severe complications like difficulty swallowing or death have been reported.12367

How does the Unframed Virtual Cone treatment for essential tremor differ from other treatments?

The Unframed Virtual Cone treatment is a type of radiosurgery that is noninvasive and frameless, making it more accessible and potentially less risky than traditional frame-based methods. It targets the ventral intermediate nucleus of the thalamus, similar to other treatments like deep brain stimulation, but does so without the need for open surgery.12489

What is the purpose of this trial?

This trial is testing a non-surgical radiation treatment to help people with severe tremors from Essential Tremor or Parkinson's Disease who can't have traditional brain surgery. The treatment aims to reduce shaking by targeting specific brain areas with precise radiation. This minimally invasive alternative to traditional brain surgery is designed for treating tremors in conditions like Essential Tremor and Parkinson's Disease.

Research Team

Dr. John Fiveash, MD - Birmingham, AL ...

John B. Fiveash

Principal Investigator

University of Alabama at Birmingham

Eligibility Criteria

This trial is for adults with severe, treatment-resistant shaking (tremor) due to Essential Tremor or Parkinson's Disease who can't have deep brain stimulation because of health issues or personal choice. They should be able to perform daily activities with minimal assistance (ECOG status 0-2).

Inclusion Criteria

All patients must be given written informed consent.
I am able to care for myself and up and about more than 50% of my waking hours.
I have severe tremor from Parkinson's or essential tremor and cannot or choose not to have DBS surgery.

Exclusion Criteria

You cannot have an MRI because of a medical reason, such as having a pacemaker.
I have had brain radiation therapy before.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive 130 Gy Virtual Cone Radiosurgery Unframed (Face Mask)

1 day
1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

36 months
Regular follow-up visits

Treatment Details

Interventions

  • Unframed Virtual Cone
Trial Overview The study tests a non-invasive procedure called Virtual Cone Radiosurgical Thalamotomy, which targets the brain area causing tremors. It aims to reduce tremors in patients who haven't improved with medication and aren't suitable for surgery.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: 130 Gy Radiation & Unframed Virtual ConeExperimental Treatment1 Intervention
130 Gy Virtual Cone Radiosurgery Unframed (Face Mask)

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Alabama at Birmingham

Lead Sponsor

Trials
1,677
Recruited
2,458,000+

Findings from Research

Gamma knife stereotactic radiosurgical thalamotomy is a safe and well-tolerated treatment option for patients with intractable tremor who have not responded to medical therapy and are not surgical candidates, based on a systematic review of available literature.
While complications can occur, they are generally mild and include issues like contralateral numbness and transient hemiparesis, with severe complications being rare; this suggests that the procedure has a favorable safety profile when using doses between 130 to 150 Gy.
Gamma knife stereotactic radiosurgical thalamotomy for intractable tremor: a systematic review of the literature.Campbell, AM., Glover, J., Chiang, VL., et al.[2022]

References

Assessing the clinical outcome of Vim radiosurgery with voxel-based morphometry: visual areas are linked with tremor arrest! [2018]
Noninvasive Thalamotomy for Refractory Tremor by Frameless Radiosurgery. [2022]
Metabolic Positron Emission Tomography Response to Gamma Knife of the Ventral Intermediate Nucleus in Essential Tremor. [2020]
Diffusion tractography imaging-guided frameless linear accelerator stereotactic radiosurgical thalamotomy for tremor: case report. [2019]
Margin of error for a frameless image guided radiosurgery system: Direct confirmation based on posttreatment MRI scans. [2022]
Gamma knife stereotactic radiosurgical thalamotomy for intractable tremor: a systematic review of the literature. [2022]
Stereotactic radiosurgery for tremor: systematic review. [2019]
Deep brain stimulation and frameless stereotactic radiosurgery in the treatment of bilateral parkinsonian tremor: target selection and case report of two patients. [2011]
Targeting for stereotactic radiosurgical thalamotomy based on tremor treatment response. [2023]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security